鹽酸川芎嗪雜質(zhì)Ⅰ(鄰苯二甲酸二甲酯)
|
PCL-#-Chp0288-50mg
|
≥95% 雜質(zhì)對照品 |
131-11-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸川芎嗪雜質(zhì)Ⅰ(鄰苯二甲酸二甲酯)
|
PCL-#-Chp0288-25mg
|
≥95% 雜質(zhì)對照品 |
131-11-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅴ雜質(zhì)E(N-去甲基大觀霉素)(2R,4αR,5αR,6S,7S,8R,9S,9αR,10αS)-6-氨基-4α,7,9-三羥基-2-甲基-8-(甲氨基)十氫-4H-吡喃并[2,3-b][l,4]苯并二噁英-4酮
|
PCL-#-Chp0287-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0287-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅴ雜質(zhì)E(N-去甲基大觀霉素)(2R,4αR,5αR,6S,7S,8R,9S,9αR,10αS)-6-氨基-4α,7,9-三羥基-2-甲基-8-(甲氨基)十氫-4H-吡喃并[2,3-b][l,4]苯并二噁英-4酮
|
PCL-#-Chp0287-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0287-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅳ雜質(zhì)D(雙羥大觀霉素)(2R,3R,4S,4αS,5αR,6S,7S,8R,9S,9αR,10αS)-2-甲基-6,8-雙(甲氨基)十氫-2H-吡喃并[2,3-b][l,4]苯并二噁英-3,4,4a,7,9-五醇
|
PCL-#-Chp0286-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0286-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅳ雜質(zhì)D(雙羥大觀霉素)(2R,3R,4S,4αS,5αR,6S,7S,8R,9S,9αR,10αS)-2-甲基-6,8-雙(甲氨基)十氫-2H-吡喃并[2,3-b][l,4]苯并二噁英-3,4,4a,7,9-五醇
|
PCL-#-Chp0286-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0286-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅲ雜質(zhì)C[(4R)-雙氫大觀霉素(活性小組分)](2R,4R,4αS,5αR,6S,7S,8R,9S,9αR,10αS)-2-甲基-6,8-雙(甲氨基)十氫-2H-吡喃并[2,3-b][1,4]苯并二噁英-4,4α,7,9-四醇
|
PCL-#-Chp0285-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0285-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅲ雜質(zhì)C[(4R)-雙氫大觀霉素(活性小組分)](2R,4R,4αS,5αR,6S,7S,8R,9S,9αR,10αS)-2-甲基-6,8-雙(甲氨基)十氫-2H-吡喃并[2,3-b][1,4]苯并二噁英-4,4α,7,9-四醇
|
PCL-#-Chp0285-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0285-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅲ雜質(zhì)C[(4S)-雙氫大觀霉素](2R,4S,4αS,5αR,6S,7S,8R,9S,9αR,10αS)-2-甲基-6,8-雙(甲氨基)十氫-2H-吡喃并[2,3-b][1,4]苯并二噁英-4,4α,7,9-四醇
|
PCL-#-Chp0284-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0284-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅲ雜質(zhì)C[(4S)-雙氫大觀霉素](2R,4S,4αS,5αR,6S,7S,8R,9S,9αR,10αS)-2-甲基-6,8-雙(甲氨基)十氫-2H-吡喃并[2,3-b][1,4]苯并二噁英-4,4α,7,9-四醇
|
PCL-#-Chp0284-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0284-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅱ雜質(zhì)B(壯觀霉素酸)(2S,3RS,5R)-3-羥基-5-甲基-2-[[(1r,2R,3S,4r,5R,6S)-2,4,6-三羥基-3,5-雙(甲氨基)環(huán)己基]氧基]-四氫呋喃-3-羧酸
|
PCL-#-Chp0283-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0283-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅱ雜質(zhì)B(壯觀霉素酸)(2S,3RS,5R)-3-羥基-5-甲基-2-[[(1r,2R,3S,4r,5R,6S)-2,4,6-三羥基-3,5-雙(甲氨基)環(huán)己基]氧基]-四氫呋喃-3-羧酸
|
PCL-#-Chp0283-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0283-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅰ雜質(zhì)A(放線茵胺)1,3-二脫氧-1,3-雙(甲氨基)-肌醇
|
PCL-#-Chp0282-50mg
|
≥95% 雜質(zhì)對照品 |
6216-38-2 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸大觀霉素雜質(zhì)Ⅰ雜質(zhì)A(放線茵胺)1,3-二脫氧-1,3-雙(甲氨基)-肌醇
|
PCL-#-Chp0282-25mg
|
≥95% 雜質(zhì)對照品 |
6216-38-2 |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸乙胺丁醇雜質(zhì)Ⅲ[(R,R)-乙胺丁醇](2R,2'R)-2,2'-(乙二基亞氨基)-雙-1-丁醇
|
PCL-#-Chp0281-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0281-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸乙胺丁醇雜質(zhì)Ⅲ[(R,R)-乙胺丁醇](2R,2'R)-2,2'-(乙二基亞氨基)-雙-1-丁醇
|
PCL-#-Chp0281-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0281-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸乙胺丁醇雜質(zhì)Ⅱ(內(nèi)消旋-乙胺丁醇)(2R,2'S)-2,2'-(乙二基二亞氨基)-雙-1-丁醇
|
PCL-#-Chp0280-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0280-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸乙胺丁醇雜質(zhì)Ⅱ(內(nèi)消旋-乙胺丁醇)(2R,2'S)-2,2'-(乙二基二亞氨基)-雙-1-丁醇
|
PCL-#-Chp0280-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0280-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
鹽酸乙胺丁醇雜質(zhì)Ⅰ[(+)2-氨基丁醇]
|
PCL-#-Chp0279-50mg
|
≥95% 雜質(zhì)對照品 |
5856-63-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
鹽酸乙胺丁醇雜質(zhì)Ⅰ[(+)2-氨基丁醇]
|
PCL-#-Chp0279-25mg
|
≥95% 雜質(zhì)對照品 |
5856-63-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
復(fù)方鹽酸阿米洛利片雜質(zhì)Ⅰ(4-氨基-6-氯苯-1,3-二磺酰胺)
|
PCL-#-Chp0278-50mg
|
≥95% 雜質(zhì)對照品 |
121-30-2 |
50mg
|
咨詢
|
咨詢 |
PCL |
復(fù)方鹽酸阿米洛利片雜質(zhì)Ⅰ
|
PCL-#-Chp0278-25mg
|
≥95% ,雜質(zhì)對照品 |
121-30-2 |
25mg
|
¥ 150.0
|
3-5天 |
PCL |
氫溴酸加蘭他敏雜質(zhì)Ⅰ(氫溴酸力克拉敏)11-甲基-3-甲氧基-4a,5,7,8,9,10,11,12-八氫-6H-苯并呋喃并[3a,3,2-ef][2]苯并氮雜?-6-醇
|
PCL-#-Chp0277-50mg
|
≥95% 雜質(zhì)對照品 |
21133-52-8 |
50mg
|
咨詢
|
咨詢 |
PCL |
氫溴酸加蘭他敏雜質(zhì)Ⅰ(氫溴酸力克拉敏)11-甲基-3-甲氧基-4a,5,7,8,9,10,11,12-八氫-6H-苯并呋喃并[3a,3,2-ef][2]苯并氮雜?-6-醇
|
PCL-#-Chp0277-25mg
|
≥95% 雜質(zhì)對照品 |
21133-52-8 |
25mg
|
咨詢
|
咨詢 |
PCL |